Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling

  • Huaiyu Yang
  • , Wei Dou
  • , Jing Lou
  • , Ying Leng*
  • , Jianhua Shen
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a potential target for treatment of diabetes and metabolic syndrome. Docking and pharmacophore modeling have been used to discover novel inhibitors of 11β-HSD1. Several compounds, with large structural diversity and good potency against 11β-HSD1, have been found and their potency was determined by the enzyme assay. New scaffolds of 11β-HSD1 inhibitors are also reported.

Original languageEnglish
Pages (from-to)1340-1345
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume18
Issue number4
DOIs
StatePublished - 15 Feb 2008
Externally publishedYes

Keywords

  • 11β-HSD1
  • 11β-HSD2
  • Docking
  • Inhibitor
  • Pharmacophore

Fingerprint

Dive into the research topics of 'Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling'. Together they form a unique fingerprint.

Cite this